Thomas Tuschl

Dr. Thomas Tuschl is a Professor of RNA Molecular Biology at Rockefeller University. Dr. Tuschl is world renown for his research into the regulation of RNA and has discovered small interfering RNAs (siRNAs), microRNAs (miRNAs), and piwi-interacting RNAs (piRNAs). He is a member of the German National Academy of Sciences and the recipient of numerous awards, including the NIH Director’s Transformative Research Project Award, the Ernst Jung Prize, the Max Delbrück Medal, the Molecular Bioanalytics Prize, the Meyenburg Prize, the Wiley Prize, and the AAAS Newcomb Cleveland Prize. He is also the co-founder and a former Director of Alnylam Pharmaceuticals (NASDAQ: ALNY). Dr. Tuschl earned his BS in Chemistry from Regensburg University and a Ph.D. from the Max Planck Institute for Experimental Medicine in Göttingen, Germany. Prior to Rockefeller, Dr. Tuschl was Group Leader at the Max Planck Institute for Biophysical Chemistry and a postdoctoral fellow at MIT and the Whitehead Institute for Biomedical Research.